Sex Differences in Differentiated Thyroid Cancer. | Sex Differences in Differentiated Thyroid Cancer. [Review] (Record no. 847)

MARC details
000 -LEADER
fixed length control field 03170nam a22005057a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220221s20212021 xxu||||| |||| 00| 0 eng d
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1089/thy.2021.0361 [doi]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 34969307
245 ## - TITLE STATEMENT
Title Sex Differences in Differentiated Thyroid Cancer.
245 ## - TITLE STATEMENT
Title Sex Differences in Differentiated Thyroid Cancer. [Review]
251 ## - Source
Source Thyroid. 32(3):224-235, 2022 03.
252 ## - Abbreviated Source
Abbreviated source Thyroid. 32(3):224-235, 2022 03.
252 ## - Abbreviated Source
Former abbreviated source Thyroid. 2021 Dec 31
253 ## - Journal Name
Journal name Thyroid : official journal of the American Thyroid Association
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2022
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2022
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Publication date 2021 Dec 31
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status ppublish
266 ## - Date added to catalog
Date added to catalog 2022-02-21
268 ## - Previous citation
-- Thyroid. 2021 Dec 31
501 ## - WITH NOTE
Local holdings Available online from MWHC library: August 2000 - present, Available in print through MWHC library: 1999 - 2006
520 ## - SUMMARY, ETC.
Abstract Sex dimorphism strongly impacts tumor biology with most cancers having a male predominance. Uniquely, thyroid cancer is the only non-reproductive cancer with striking female predominance with 3-4-fold higher incidence among females, although males generally have more aggressive disease. The molecular basis for this observation is not known and current approaches in treatment and surveillance are not sex specific. Although thyroid cancer has overall good prognosis, 6-20% of patients develop regional or distant metastasis, one third of whom are not responsive to conventional treatment approaches and suffer a 10-year survival rate of only 10%. More efficacious treatment strategies are needed for these aggressive thyroid cancers as tyrosine kinase inhibitors and immunotherapy have major toxicities without demonstrable overall survival benefit. Emerging evidence indicates a role of sex-hormones, genetics and the immune system in modulation of both risk for thyroid cancer and its progression in a sex-specific manner. Greater understanding of the molecular mechanisms underlying sex-differences in thyroid cancer pathogenesis could provide insights to the development of sex-specific, targeted, effective strategies for prevention, diagnosis, and management. This review summarizes emerging evidence for the importance of sex in the pathogenesis, progression, and response to treatment in differentiated thyroid cancer with emphasis on the role of sex-hormones, genetics and the immune system.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Adenocarcinoma
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Thyroid Neoplasms
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sex Characteristics
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thyroid Neoplasms/ep [Epidemiology]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thyroid Neoplasms/ge [Genetics]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thyroid Neoplasms/th [Therapy]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Medicine/Endocrinology
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Burman, Kenneth D
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Shobab, Leila
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Wartofsky, Leonard
790 ## - Authors
All authors Burman KD, Shobab L, Wartofsky L
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1089/thy.2021.0361">https://dx.doi.org/10.1089/thy.2021.0361</a>
Public note https://dx.doi.org/10.1089/thy.2021.0361
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 02/21/2022   34969307 34969307 02/21/2022 02/21/2022 Journal Article

Powered by Koha